Company: BOLT
Filing Date: 2025-03-24
Form Type: 10-K
Source: 0000950170-25-043873
Chunk: 7

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-03-24
Form: 10-K
Item: Item 15
Chunk 7
---
 the Leland Stanford Junior University, dated May  18, 2015, as amended by Amendment No. 1 to Exclusive (Equity) Agreement by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University, dated August 2, 2016, and Amendment No. 2 to Exclusive (Equity) Agreement by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University dated June 25, 2018.
     
    S-1
     
    333-252136
     
    10.20
     
    1/15/2021

    10.17
     
    Sales Agreement, by and between the Registrant and Cowen and Company, LLC dated March 30, 2022.
     
    S-3 
     
    333-263994 
     
    1.2 
     
    3/30/2022 

    10.18+
     
    Amended and Restated Severance and Change in Control Plan.
     
    10-K
     
    001-39988
     
    10.24
     
    3/29/2023

    10.19
     
    First Amendment to Britannia Seaport Centre Lease by and between the Registrant and HCP LS Redwood City, LLC, dated November 7, 2022.
     
    10-K
     
    001-39988
     
    10.25
     
    3/29/2023

    19.1
     
    Insider Trading Policy

    X

    21.1
     
    Subsidiaries of the Registrant 

    X

    23.1
     
    Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm.

    X

    24.1
     
    Power of Attorney (see signature page to this Annual Report on Form 10-K).

    X

121

Table of Contents

    ExhibitNumber
     
    Description of Exhibit
     
    Form
     
    File No.
     
    Exhibit
     
    Filing Date
     
    FiledHerewith

    31.1
     
    Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rules 13a-14(a) and